Orthorexia: When 'pure' eating goes too far

SAN JOSE, Calif. — During a new outing to a Half Moon Bay, Calif., farmers market, Johnny Righini didn’t humour a panic conflict or disapprove his mom when she bought nonorganic produce. For Righini, this impulse of reserve noted another tiny feat in his onslaught to overcome a pathological mania with eating „pure” foods.

Starting in his early 20s, Righini dedicated himself to vegan and tender food diets, meditative they offering a healthy approach to redeem from years of anorexia and bulimia. But he took those limiting diets to extremes, agonizing, for example, over fruits and vegetables losing their „life force” any notation after being picked.

He now says his „twisted thinking” was a sign of orthorexia, an eating commotion that is increasingly on a radar of health professionals.

Righini didn’t obsess over calorie counts, as he did with anorexia. He pored over part labels — afterwards deserted food with labels as being too „impure.” He found it unfit to eat out during restaurants or other people’s homes or to be around people eating quick food. He even tossed out food his mom brought home from a supermarket.

„Just as we limited myself from food, we limited myself from people,” he said. „If they were eating something my orthorexic mind didn’t approve of, we would get earthy shakes and panic attacks.”

Eating commotion experts contend there is zero wrong with wanting to eat nutritiously or to discharge certain foods. But healthy eating becomes damaging when people’s meditative or function becomes so „extremely rigid” they jeopardise their earthy and mental health and relations with other people, pronounced Jennifer Lombardi, executive executive of a Eating Recovery Center in Sacramento.

„Any diet or dietary limitation that causes a chairman to be incompetent to applaud and consort with food absolutely is going too far,” concluded Leah Hopkins, a clinical dietitian during a Monarch Cove Eating Disorder Treatment Center in Pacific Grove, Calif.

It’s not startling that people fervently fasten onto health food trends, generally in Northern California, where a foodie enlightenment equates rational eating with a happy life and disparages mixture that are not organic, healthy or locally produced.

„Some of my colleagues call it a ‚Whole Foods syndrome,’” says Katie Bell, medical executive and a psychiatric helper practitioner during a Healthy Teen Project in Los Gatos, Calif. She combined that an initial choice to cut out sugar, processed dishes or other oft-labeled „bad” dishes wins orthorexics regard from others who admire their self-discipline and slimming figures.

Orthorexia became a prohibited amicable media subject this open when Jordan Younger, a Blonde Vegan blogger, dismayed her 70,000 Instagram supporters with news that she had a eating disorder. She pronounced she cut out options that even fell underneath a vegan powerful since they were „not 100 percent purify or 100 percent raw,” she told People magazine. „I was following thousands of manners in my conduct that were creation me sick.”

Orthorexia, distinct a some-more well-studied disorders of anorexia and bulimia, has not done a approach into a Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, a concept management for psychiatric diagnoses.

Sleep problems common among toddlers with psychiatric disorders

„The many common nap problems reported nationally for toddlers and preschoolers are problems of going to bed, descending defunct and visit night awakenings — collectively, these problems are referred to as behavioral insomnias of childhood,” pronounced Boekamp. „Sleep problems in immature children frequently co-occur with other behavioral problems, with justification that unsound nap is compared with daytime sleepiness, reduction optimal preschool adjustment, and problems of irritability, hyperactivity and attention.”

Boekamp’s organisation was meddlesome in training some-more about nap and nap problems in immature children with function problems, as early nap problems competence be both a means and effect of children’s problems with behavioral and romantic self-regulation. „Essentially, these immature children competence be held in a cycle, with nap intrusion inspiring their psychiatric symptoms and psychiatric symptoms inspiring their sleep-wake organization,” pronounced Boekamp.

The prejudiced module that Boekamp leads during Bradley Hospital is a family-centered, complete day diagnosis module for really immature children aged from baby to 6 who have vicious emotional, behavioral or attribute disturbances. This investigate examined a inlet and superiority of diagnostically tangible nap disorders, including Sleep Onset Insomnia (SOI) and Night Waking Insomnia (NWI), in a organisation of 183 immature children certified to a program. Diagnosable nap disorders, utterly SOI, were utterly common in a group, surpassing prior estimates performed in village settings. Overall, 41 percent of children in a investigate also met evidence criteria for a nap disorder. Sleep problems were generally common in children with disruptive behavior, attention, stress and mood problems.

„It is vicious for families to be wakeful of how vicious nap is to a behavioral composition and wellbeing of immature children,” pronounced Boekamp. „Sleep disorders competence be unrecognized and under-diagnosed in immature children, utterly when other behavioral or romantic problems are present.”

Difficulties with nap competence be utterly vicious to residence when children are also struggling with severe daytime behaviors, such as problems with compliance, aggression, courtesy and mood. Sleepiness and tired competence intensify these problem behaviors.

„This investigate is a good sign that it’s vicious for mental health providers operative with immature children and their families to ask about children’s sleep,” pronounced Boekamp. „Simple questions about children’s nap patterns, including how prolonged it takes a child to tumble defunct during night and how frequently a child awakens after descending asleep, competence produce vicious information that is applicable to clinical care, even when nap problems are not a primary concentration of treatment.”

Health minister: Mali confirms the initial Ebola case


A proffer receives a Ebola vaccination „cAd3-EBO-Z” during a vaccine core in Bamako, Mali, on Oct. 9. (Alex Duval Smith/EPA)

Mali’s health apportion confirmed Thursday that a West African nation has a initial Ebola case.

Health Minister Ousmane Kone told state radio Thursday that a studious is a 2-year-old lady in a Kayes segment in a west of a country, Reuters reported. The lady recently came from Guinea, a apportion added, that neighbors Kayes to a south.

The condition of a girl, according to a services, is improving interjection to her fast treatment,” a apportion said, according to a Reuters report. He added, „the ill child and a people who were in strike with her in Kayes were immediately identified and taken caring of.” 

According to a health minister, a patient’s blood tested certain for Ebola after she was admitted to a hospital Wednesday evening, a AP notes.

Although a World Health Organization recently announced adjacent Senegal Ebola-free after a singular box of a pathogen there, Guinea is one of 3 West African countries strike tough by a outbreak.

Since a commencement of a outbreak, a World Health Organization has counted 9,936 confirmed, illusive and suspected cases of Ebola in seven countries: Guinea, Liberia, Sierra Leone, Spain, a United States, Nigeria and Senegal.

The immeasurable infancy of those cases are in Guinea, Sierra Leone and Liberia. Along with Senegal, a WHO has also dynamic that Nigeria is now Ebola-free.

There have been 4,877 reliable deaths in a stream outbreak.

Guinea alone has 1,540 cases of a illness and 904 deaths, according to a latest accessible total from a WHO.

[This post has been updated]

First box of Ebola reliable in Mali: health ministry

Bamako (AFP) – Mali’s health method on Thursday pronounced a nation had a initial reliable box of Ebola after a two-year-old lady who had recently been in Guinea tested certain for a virus.

„Today Mali has a initial alien box of a Ebola virus,” a method pronounced in a statement. The lady was diagnosed after she arrived during a sanatorium in a western city of Kayes on Wednesday, it added.

The child and those she has come into hit with have been put in isolation.

The temperament of a putrescent lady was not released.

Health method orator Markatche Daou told AFP that she had trafficked to beside Guinea with her grandmother and that a authorities were wakeful of her itinerary.

The method pronounced a lady had visited Kissidougou, a city in a southern partial of Guinea where a Ebola conflict was initial identified in Dec 2013.

„Everyone who had hit with a lady is underneath medical surveillance,” he said.

The west African nations of Guinea, Liberia and Sierra Leone have borne a brunt of a lethal Ebola virus.

According to World Health Organization total 10,000 people have been putrescent and roughly 4,900 have died of a illness in west Africa.

Mali’s health method pronounced all required stairs had been taken to equivocate a widespread of Ebola, and called on residents to sojourn calm.

However it warned opposite all nonessential transport to influenced areas and urged hygiene and reserve measures to be respected.

In Apr there were some suspected Ebola cases in Mali, yet these valid to be fake alarms.

In Aug Senegal also purebred a reliable Ebola case, alien from Guinea. That box did not widespread and final week Senegal was announced Ebola-free.

International alarm has been stoked by cases over Africa.

Spain has seen one non-fatal infection, a helper who held Ebola from a studious she cared for — a companion who died of a illness after returning from Liberia.

In a United States, dual nurses fell ill after caring for a Liberian male who died from a illness on Oct 8, a initial Ebola box to be diagnosed on US soil.

So far, yet clinical trials are underway, no vaccine has been constructed for a illness that is transmitted by corporeal fluids, withdrawal health workers generally during risk.

More health word changes on a way

Employers are increasingly pulling enrollment in high-deductible, low-premium health word plans, according to advantages experts, that means it competence be time to mangle out a calculator and recur stream policies.

Employees in Chicago and opposite a nation are removing their initial looks during what they will be profitable for health word in 2015 with a start of open enrollment, a annual window in that workers can make changes to their inaugurated benefits, including health insurance. Open enrollment is typically hold in Oct and Nov any year.

„Don’t assume that nothing’s changing even if your stream choice is still available,” pronounced Craig Rosenberg, use personality of health and gratification advantages during consulting organisation Aon Hewitt. „There are substantially some new choices that are accessible for you.”

Three-fourths of employers aim to offer high-deductible skeleton joined with a health assets comment in a subsequent 3 years, and 20 percent will usually offer those form of plans, according to information from Mercer, a financial services association with a health and advantages arm. To validate for a health assets account, a devise has to have a smallest deductible of $1,250 for employee-only coverage and $2,500 for family coverage. Others are charity private health exchanges, that give employees several options for coverage.

Overall costs approaching will arise again in 2015, by about 4 percent, according to Mercer, medium compared with prior years. But some employees are observant most crook increases, creation high-deductible skeleton some-more attractive. Consumers who opt not to obtain coverage, possibly by their employer or by a sovereign Affordable Care Act, will also compensate more. Those people will compensate a larger chastisement for not securing coverage, augmenting to $325, or 2 percent of domicile income, whichever cost is greater, from $95 this year, or 1 percent of yearly domicile income.

High-deductible, low-premium skeleton are mostly called consumer-directed health skeleton and interconnected with a health assets comment that allows workers to compensate for authorised losses with tax-free dollars, experts said.

Employers have a financial inducement to offer such plans. Under a Affordable Care Act, employers in 2018 that offer skeleton that cost some-more than $10,200 for an particular or $27,500 for a family will be charged a 40 percent taxation on a volume surpassing a threshold. By lifting deductibles and obscure premiums, companies will reduce their possibility of triggering a tax.

Beth Umland, executive of investigate for health and advantages for Mercer, pronounced some-more than one-third of companies would strike that dig taxation threshold if they done no changes to their devise offerings.

Premiums in consumer destined skeleton typically cost about 20 percent reduction than a normal PPO or HMO plan, she said.

„If you’ve been frightened off of consumer destined plans, this competence be a year to man-up and take a look,” Umland said. „Employers wish to get people into those skeleton for a accumulation of reasons. That’s a devise where they see long-term cost control, so to get folks to join it, it’s discount groundwork reward contributions.”

Nancy Coletto, a Chicago-based partner in Mercer’s health and advantages practice, pronounced employer health word skeleton are some-more approaching to supplement an additional cost for dependents (spouses and adult children) who have entrance to health word during another workplace this year.

„Health caring remodel puts some-more shortcoming on employers to cover some-more of their employees,” Coletto said. „Employers who are now covering some-more employees competence make it some-more costly to cover a dependent. Make certain we entirely know what costs are changing. That preference competence be opposite than what it was before.”

Private exchanges — run by companies like Aon Hewitt, Mercer, Buck Consultants and Towers Watson — are likely to grow in recognition in entrance years, with 33 percent of some-more than 1,200 companies surveyed by Aon Hewitt observant they would cite to offer a private health sell in a subsequent 3 to 5 years. Just 5 percent will use a private health sell in 2015.

Aon Hewitt started a private sell module for active employees 3 years ago with 3 companies. In 2015, Aon Hewitt anticipates about 30 companies will enroll its exchange, covering 850,000 employees and dependents. Mercer has sealed adult 170 companies in a private sell for 2015, covering 975,000 active employees and dependents. The private health exchanges offer a accumulation of plans, from PPOs, some-more costly month to month, to low-premium consumer destined plans.

„Don’t only buy on cost alone,” Rosenberg said, „and instead demeanour during a whole situation. … Look during how most you’ll spend out of slot when we use a devise via a year. … You competence find that a lowest-cost devise that we could buy competence not finish adult being a lowest-cost devise with how we would use it.”

ehirst@tribune.com

Twitter @ellenjeanhirst

Tips for health word enrollment

Assess your needs

How most did we spend on health caring out of slot final year? Ask your health devise provider for your past medical and dental claims to calculate final year’s costs.

Account for any vast changes

Are we formulation to have a baby? Did someone in your family rise a new medical condition?

Evaluate a network

Mergers among doctors groups as good as sanatorium systems are reshaping a provider community, that could impact your choices.

Decide either a consumer driven health devise is right for you

These reduce how most income is taken out of any paycheck though leave we with a vast deductible if anything happens. Couple this with a health assets comment to assistance compensate for out-of-pocket costs.

Determine either to put a contingent on a same plan

If your associate or adult child has entrance to health caring by another provider, it competence be some-more cost-effective to have him or her enroll with his or her employer plan, depending on fees.

Take advantage of health and wellness programs

Some companies offer financial incentives for completing certain questionnaires or several health-related activities.

Know how your coverage relates to open Affordable Care Act exchanges

If you’re authorised for health caring by your employer, we won’t get sovereign taxation credits to buy word by a open exchanges.

SOURCES: Adapted from materials and interviews with experts from Aon Hewitt, Mercer and a Employee Benefits Research Institute

Copyright © 2014, Chicago Tribune

Fresno center propagandize tyro hospitalized after eating pot brownies

A center propagandize tyro was hospitalized after immoderate marijuana-laced brownies that he pronounced he purchased from a 12-year-old child on a Fresno campus, military pronounced Thursday.

The child purchased a brownies Wednesday from a seventh-grade tyro during Sequoia Middle School for $5, ate them and afterwards went to revisit his dentist, Fresno Police Lt. Joe Gomez said. 

During a visit, a child mislaid alertness and was taken to a hospital, where doctors reliable he was underneath a change of marijuana.

lRelated 1 of 5 teenagers disgusted by pot brownies indispensable resuscitation, military say
L.A. Now1 of 5 teenagers disgusted by pot brownies indispensable resuscitation, military saySee all related

The boy, who also a seventh-grade student, told his mom about a brownies.

School administrators called military and a tyro indicted of offered a brownies into their bureau Thursday. The child had brought another collection of pot brownies — all of that were away wrapped — to school, Gomez said.

The child told military that his hermit had a medical pot permit and kept a brownies in their home fridge to provide his behind pain.

The child „knew a brownies were in a fridge and he motionless to take them and sell them to other students during propagandize to make some money,” Gomez said.

Although a tyro dictated to a sell a brownies to „prospective customers” on campus, Gomez said, they „wanted a brownies for free” and his try was not successful.

The student, he said, will substantially face drug charges.

For violation news in Los Angeles and via California, follow @VeronicaRochaLA. She can be reached at veronica.rocha@latimes.com.

Copyright © 2014, Los Angeles Times

Global Sleep Apnea Diagnostic and Therapeutic Devices Market

NEW YORK, Oct. 23, 2014 /PRNewswire/ — This news analyzes a worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Thousands by a following Product Segments: Diagnostic Devices, and Therapeutic Devices. The news provides apart extensive analytics for a US, Canada, Japan, Europe, Asia-Pacific, Middle East Africa, and Latin America. Annual estimates and forecasts are supposing for a duration 2013 by 2020. Also, a seven-year ancestral investigate is supposing for these markets. Market information and analytics are subsequent from primary and delegate research. Company profiles are essentially formed on open domain information including association URLs. The news profiles 71 companies including many pivotal and niche players such as -

Cadwell Laboratories, Inc.
CareFusion Corporation
Cleveland Medical Devices, Inc.
Compumedics Ltd.
DeVilbiss Healthcare

Read a full report: http://www.reportlinker.com/p01048443-summary/view-report.html

I. INTRODUCTION, METHODOLOGY PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation Reporting Level I-2
Quantitative Techniques Analytics I-3
Product Definitions and Scope of Study I-3
Diagnostic Devices I-3
Clinical/Fixed Polysomnographs I-3
Ambulatory Polysomnographs (Ambulatory PSG) I-3
Others (include Screening Devices) I-3
Therapeutic Devices I-4
Continuous-Positive Airway Pressure (CPAP) I-4
Auto-titrating Positive Airway Pressure (Auto PAP) I-4
Bi-Level Positive Airway Pressure (Bi-Level PAP) I-4
Facial Interfaces (Masks and Humidifiers) I-4

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW II-1
A Prelude II-1
US, a Clear Market Leader; Developing Regions Promise Growth II-1
Sleep Apnea Therapeutic Devices – The Largest Product Segment II-2
ResMed and Respironics Dominate Competitive Landscape II-2
Table 1: Global Sleep-Disordered Breathing (SDB) Devices
Market by Leading Players (2012): Market Share Breakdown for
Fisher Paykel, Philips Respironics, ResMed, and Others
(includes analogous Graph/Chart) II-3
OSA Industry Witnesses Consistent MA Activity II-3

2. MARKET TRENDS AND DYNAMICS II-5
Outlook for Global Healthcare II-5
Table 2: Healthcare Spending as a Percentage of GDP in Select
Developed Countries (includes analogous Graph/Chart) II-6
Impact of Economic Recession on a Medical Device Industry II-6
Reimbursement Policies of CMS/Insurance Agencies II-7
Home Sleep Testing (HST) Gaining Popularity II-7
Table 3: World Home Healthcare Devices Market (2014):
Percentage Share of Medical Devices Value Sales for Diabetic
Care Monitors Kits, Blood Pressure Monitors, Sleep Apnea
Monitors, Pregnancy and Fertility Kits, and Other Devices
(includes analogous Graph/Chart) II-7
Patient-Centric Initiative II-8
Increased Awareness of Comorbid Conditions Spurs Market Growth II-8
Table 4: Percentage Prevalence of Sleep Apnea in
Co-Morbidities by Type of Co-Morbidity (includes
corresponding Graph/Chart) II-8
Obesity: An Opportunity Indicator for Sleep Apnea Market II-9
Table 5: Overweight and Obese Population (in Millions) by
Geographic Region (2013) (includes analogous Graph/Chart) II-9

Table 6: Global Obesity Levels (2013): Percentage Share
Breakdown of Total Obese/ Overweight Population by Leading
Countries (includes analogous Graph/Chart) II-9

Table 7: Prevalence of Adult Obesity in Select Countries
(2013) (includes analogous Graph/Chart) II-10
Technology Advancements Improve Patient Compliance II-10
Humidification II-10
Patient-Friendly Masks II-11
Educational Campaigns II-11
Newer CPAP Alternatives II-11
Emergence of Dental Sleep Medicine II-11
Oral Appliances vs. CPAP II-11
Sleep Apnea/Sleep Disorders in Children Responsible for Obesity II-12
Changing Demographics to Play a Major Role II-12

3. SLEEP APNEA – A SYNOPSIS II-13
Significance of Sleep II-13
Stages of Sleep II-13
Sleep Disorders and Stages of Sleep II-13
Sleep Apnea- Introduction II-13
Forms of Apnea II-14
Central Sleep Apnea II-14
Physiological Effects of CSA II-14
Mixed Apnea II-14
Complex Sleep Apnea II-14
Obstructive Sleep Apnea – An Overview II-15
History II-15
Causes of OSA II-15
Symptoms of OSA II-16
Snoring and OSA II-16
Risks and Complications Associated with Untreated Disorder II-16
Risk Groups II-16
Co-Morbid Conditions II-17
Heart Failure II-17
Hypertension II-17
Diabetes II-17
Fatigue II-17
Complications Associated with Surgery and Medications II-17
Financial Implications of Untreated OSA II-18
Pediatric OSA II-18

4. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES II-19
OSA Diagnosis II-19
Interpreting AHI II-19
AHI of 5 to 15: Mild OSA II-19
AHI of 15 to 30: Moderate OSA II-19
AHI of some-more than 30: Severe OSA II-19
Sleep Apnea Diagnostic Devices II-19
Polysomnography (PSG), and Types of Polysomnographs II-19
Clinical/Fixed Polysomnographs II-20
Ambulatory Polysomnographs II-20
Other Sleep Apnea Diagnostic Devices II-21
Screening Devices II-21
Actigraphs II-21
Sleep Apnea Therapeutic Devices II-21
Positive Airway Pressure (PAP) Treatment II-21
PAP Devices II-21
Continuous Positive Airway Pressure (CPAP) Devices II-21
Optional Features Available for CPAP Devices II-22
Auto-titrating Positive Airway Pressure (APAP) Devices II-22
Bi-Level Positive Airway Pressure (BiPAP) Devices II-23
Facial Interfaces (Masks and Humidifiers) II-23
Alternative Apnea Therapies II-23
Oral Appliances II-23
Surgical Procedures II-24
Tracheostomy II-24
Uvulo-palato-pharyngoplasty (UPPP) II-24
Mandibular Myotomy II-24
Laser Assisted Uvuloplasty (LAUP) II-25
Somnoplasty or Radio Frequency (RF) Procedure II-25
Pillar Palatal Implant System II-25
Other Surgical Therapies II-25
Over-the-Counter and Pharmacological Therapies II-25
Behavioral and Lifestyle Changes II-26

5. RESEARCH FINDINGS IN RECENT PAST II-27
Research Finds Link between Sleep Apnea and Heart Risks in
Children II-27
Sleep Disorders Increase Risk for Stroke and Blood Pressure
Patients II-27
Individuals with Sleep Apnea Face Greater Risk of Cardiac
Stress during Air Travel II-27
Sleep Apnea Screening Reduces Risk of Post-Operative
Complications II-27

6. PRODUCT LAUNCHES/INTRODUCTIONS II-28
Zephyr to Market Health Canada-Approved MATRx II-28
ResMed Introduces AirFit P10 Nasal System II-28
InnoMed Launches Aspen CPAP Mask II-28
Philips Unveils New Products during SLEEP2014 II-28
Philips Respironics Launches WatchPAT™ II-28
Human Design Medical Launches Z1 Device II-28
Discover Medical Develops SomnuSeal II-29
Covidien Launches Capnostream Monitor II-29
Somnetics to Market Transcend Humidifier in US II-29
Fisher Paykel Introduces Pilairo Q II-29
Circadiance Launches SleepWeaver® Anew™ II-29
CheapCPAPSupplies.com Unveils New CPAP Masks II-29
Tens Medical Services Launches New Range of CPAP Masks II-30
Sorin Group Launches Reply™200 Pacemakers II-30
ResMed Introduces Quattro Face Mask II-30
Ventus Medical Launches Provent® in Canada II-30
Circadiance Launches SleepWeaver Elan II-30
Sleep Restfully Offers RESmart CPAP II-30
APEX Medical Launches Holistic Healthcare Formula II-31
ResMed Launches Narval™ Device II-31
Omron Launches Sleep Monitor with ResMed Technology II-31
Devilbiss Unveils New CPAP Masks II-31
Circadiance Unveils SleepWeaver® Advance II-31
US Researchers Develop Novel Sleep Apnea Diagnostic Device
based on Ultrasonic Sensors II-31

7. RECENT INDUSTRY ACTIVITY II-32
PBM Capital Group Acquires Breas Medical II-32
Itamar Medical Signs Agreement with Medtronic II-32
MGC Signs Distribution Agreement with Neurovirtual II-32
Thorne Research Signs Marketing Agreement with Itamar Medical II-32
Inspire Medical Systems Raises US$40 Million to Launch Sleep
Apnea Device II-32
Dehaier Receives CFDA Approval for Sleep Diagnostic Device II-33
FDA Approves Itamar’s WatchPAT Unified II-33
Dehaier Receives CFDA Approval for Morpheus Ox Software II-33
Advanced Brain Monitoring Receives FDA Clearance for Night Shift II-33
ResMed Acquires Warsaw-based Mediserv II-33
CareFusion Acquires Vital Signs from GE Healthcare II-33
Air Liquide SA Acquires Polish Companies Ventamed and HELP II-34
Advanced Home Care Acquires Extrakare II-34
Air Liquide SA Buys Stake in Healthy Sleep Solutions II-34
WaterMark Medical Merges with SleepMed II-34
Gamma-Dynacare Collaborates with OSR Medical II-34
NovaSom Partners with Infosys II-34
Zephyr Expands Distribution Network in a US II-35
Zynex Signs Distribution Agreement with Advanced Brain Monitoring II-35
SomnoMed Expands in Korea II-35
Breathe Technologies Receives FDA Clearance for CPAP System II-35
SomnoMed Acquires MAS Nordic II-35
Sleep Nation Acquires CPAP Businesses II-35
Pier Pharmaceuticals Merges with Cortex II-36
Novogen Merges with Kai Medical II-36
Air Liquide SA to Buy Gasmedi SA II-36
Fidelis Diagnostics Partners with Nationwide Medical II-36
Watermark Medical Partners with Coventry to Offer HST II-36
SomnoMed Collaborates with Benco Dental II-36
Watermark Medical Signs Agreement with Aetna II-36
Somnetics Receives Approval for Product Distribution in Global
Markets II-37
Mylan Receives FDA Approval for Modafinil II-37
ApniCure Receives FDA Approval for Winx II-37
Dehaier Obtains CE Certification for Sleep Diagnostic Devices
and Air Compressors II-37

8. FOCUS ON SELECT PLAYERS II-38
Cadwell Laboratories, Inc. (US) II-38
CareFusion Corporation (US) II-38
Cleveland Medical Devices, Inc. (US) II-38
Compumedics Ltd. (Australia) II-39
DeVilbiss Healthcare (US) II-39
Global Medical Holdings LLC (US) II-40
Fisher Paykel Healthcare Limited (New Zealand) II-40
GE Healthcare (US) II-40
Itamar Medical Ltd. (Israel) II-41
Invacare Corporation (US) II-41
Natus Medical Inc. (US) II-41
Embla Systems, Inc. (US) II-42
Grass Technologies (US) II-42
Philips Healthcare (US) II-42
ResMed Inc. (US) II-43
Teleflex Medical (US) II-43
Weinmann Geräte für Medizin GmbH+CCo. KG (Germany) II-44

9. GLOBAL MARKET PERSPECTIVE II-45
Table 8: World Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Geographic
Region – US, Canada, Japan, Europe, Asia-Pacific, Middle East
Africa, and Latin American Markets Independently Analyzed
with Annual Sales in US$ Thousand for Years 2013 by 2020
(includes analogous Graph/Chart) II-45

Table 9: World Historic Review for Sleep Apnea Diagnostic and
Therapeutic Devices by Geographic Region – US, Canada, Japan,
Europe, Asia-Pacific, Middle East Africa, and Latin American
Markets Independently Analyzed with Annual Sales in US$
Thousand for Years 2006 by 2012 (includes corresponding
Graph/Chart) II-46

Table 10: World 15-Year Perspective for Sleep Apnea Diagnostic
and Therapeutic Devices by Geographic Region – Percentage
Breakdown of Value Sales for US, Canada, Japan, Europe,
Asia-Pacific, Middle East Africa, and Latin American Markets
for Years 2006, 2014, and 2020 (includes corresponding
Graph/Chart) II-47

Table 11: World Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic Devices by Geographic Region – US,
Canada, Japan, Europe, Asia-Pacific, Middle East Africa, and
Latin American Markets Independently Analyzed with Annual
Sales in US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) II-48

Table 12: World Historic Review for Sleep Apnea Diagnostic
Devices by Geographic Region – US, Canada, Japan, Europe,
Asia-Pacific, Middle East Africa, and Latin American Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) II-49

Table 13: World 15-Year Perspective for Sleep Apnea Diagnostic
Devices by Geographic Region – Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East
Africa, and Latin American Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) II-50

Table 14: World Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic Devices by Product Segment -
Clinical/Fixed PSG, Ambulatory PSG, and Other Devices
(Screening Devices) Markets Independently Analyzed with Annual
Sales in US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) II-51

Table 15: World Historic Review for Sleep Apnea Diagnostic
Devices by Product Segment – Clinical/ Fixed PSG, Ambulatory
PSG, and Other Devices (Screening Devices) Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) II-52

Table 16: World 15-Year Perspective for Sleep Apnea Diagnostic
Devices by Product Segment – Percentage Breakdown of Value
Sales for Clinical/Fixed PSG, Ambulatory PSG, and Other
Devices (Screening Devices) Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) II-53

Table 17: World Recent Past, Current Future Analysis for
Clinical/Fixed PSG Devices by Geographic Region – US, Japan,
Europe, and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Thousand for Years 2013 by 2020
(includes analogous Graph/Chart) II-54

Table 18: World Historic Review for Clinical/Fixed PSG Devices
by Geographic Region – US, Japan, Europe, and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Thousand for Years 2006 by 2012 (includes corresponding
Graph/Chart) II-55

Table 19: World 15-Year Perspective for Clinical/Fixed PSG
Devices by Geographic Region – Percentage Breakdown of Value
Sales for US, Japan, Europe, and Rest of World Markets for
Years 2006, 2014, and 2020 (includes corresponding
Graph/Chart) II-56

Table 20: World Recent Past, Current Future Analysis for
Ambulatory PSG Devices by Geographic Region – US, Japan,
Europe, and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Thousand for Years 2013 by 2020
(includes analogous Graph/Chart) II-57

Table 21: World Historic Review for Ambulatory PSG Devices by
Geographic Region – US, Japan, Europe, and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Thousand for Years 2006 by 2012 (includes corresponding
Graph/Chart) II-58

Table 22: World 15-Year Perspective for Ambulatory PSG Devices
by Geographic Region – Percentage Breakdown of Value Sales for
US, Japan, Europe, and Rest of World Markets for Years 2006,
2014, and 2020 (includes analogous Graph/Chart) II-59

Table 23: World Recent Past, Current Future Analysis for
Other Diagnostic Devices (Screening Devices) by Geographic
Region – US, Japan, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) II-60

Table 24: World Historic Review for Other Diagnostic Devices
(Screening Devices) by Geographic Region – US, Japan, Europe,
and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Thousand for Years 2006 by 2012 (includes
corresponding Graph/Chart) II-61

Table 25: World 15-Year Perspective for Other Diagnostic
Devices (Screening Devices) by Geographic Region – Percentage
Breakdown of Value Sales for US, Japan, Europe, and Rest of
World Markets for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) II-62

Table 26: World Recent Past, Current Future Analysis for
Sleep Apnea Therapeutic Devices by Geographic Region – US,
Canada, Japan, Europe, Asia-Pacific, Middle East Africa, and
Latin American Markets Independently Analyzed with Annual
Sales in US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) II-63

Table 27: World Historic Review for Sleep Apnea Therapeutic
Devices by Geographic Region – US, Canada, Japan, Europe,
Asia-Pacific, Middle East Africa, and Latin American Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) II-64

Table 28: World 15-Year Perspective for Sleep Apnea
Therapeutic Devices by Geographic Region – Percentage
Breakdown of Value Sales for US, Canada, Japan, Europe,
Asia-Pacific, Middle East Africa, and Latin American Markets
for Years 2006, 2014, and 2020 (includes corresponding
Graph/Chart) II-65

Table 29: World Recent Past, Current Future Analysis for
Sleep Apnea Therapeutic Devices by Product Segment – CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers) Markets Independently Analyzed with Annual Sales
in US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) II-66

Table 30: World Historic Review for Sleep Apnea Therapeutic
Devices by Product Segment – CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers) Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) II-67

Table 31: World 15-Year Perspective for Sleep Apnea
Therapeutic Devices by Product Segment – Percentage Breakdown
of Value Sales for CPAP, Auto PAP, Bi-Level PAP, and Facial
Interfaces (Masks and Humidifiers) Markets for Years 2006,
2014, and 2020 (includes analogous Graph/Chart) II-68

Table 32: World Recent Past, Current Future Analysis for
CPAP Devices by Geographic Region – US, Japan, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
in US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) II-69

Table 33: World Historic Review for CPAP Devices by Geographic
Region – US, Japan, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) II-70

Table 34: World 15-Year Perspective for CPAP Devices by
Geographic Region – Percentage Breakdown of Value Sales for
US, Japan, Europe, and Rest of World Markets for Years 2006,
2014, and 2020 (includes analogous Graph/Chart) II-71

Table 35: World Recent Past, Current Future Analysis for
Auto PAP Devices by Geographic Region – US, Japan, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
in US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) II-72

Table 36: World Historic Review for Auto PAP Devices by
Geographic Region – US, Japan, Europe, and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Thousand for Years 2006 by 2012 (includes corresponding
Graph/Chart) II-73

Table 37: World 15-Year Perspective for Auto PAP Devices by
Geographic Region – Percentage Breakdown of Value Sales for
US, Japan, Europe, and Rest of World Markets for Years 2006,
2014, and 2020 (includes analogous Graph/Chart) II-74

Table 38: World Recent Past, Current Future Analysis for
Bi-Level PAP Devices by Geographic Region – US, Japan, Europe,
and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) II-75

Table 39: World Historic Review for Bi-Level PAP Devices by
Geographic Region – US, Japan, Europe, and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Thousand for Years 2006 by 2012 (includes corresponding
Graph/Chart) II-76

Table 40: World 15-Year Perspective for Bi-Level PAP Devices
by Geographic Region – Percentage Breakdown of Value Sales for
US, Japan, Europe, and Rest of World Markets for Years 2006,
2014, and 2020 (includes analogous Graph/Chart) II-77

Table 41: World Recent Past, Current Future Analysis for
Facial Interfaces (Masks and Humidifiers) by Geographic Region -
US, Japan, Europe, and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Thousand for Years 2013
through 2020 (includes analogous Graph/Chart) II-78

Table 42: World Historic Review for Facial Interfaces (Masks
and Humidifiers) by Geographic Region – US, Japan, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
in US$ Thousand for Years 2006 by 2012 (includes
corresponding Graph/Chart) II-79

Table 43: World 15-Year Perspective for Facial Interfaces
(Masks and Humidifiers) by Geographic Region – Percentage
Breakdown of Value Sales for US, Japan, Europe, and Rest of
World Markets for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) II-80

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Sleep Disorders: Factsheet III-1
Sleep Apnea in a US: A Demographic Outline III-1
Table 44: US Healthcare Market (2014): Total Annual
Expenditure in US$ Billion by Chronic isorder/Disease for
CVD/Stroke, Obstructive Sleep Apnea (OSA), Obesity, and
Diabetes (includes analogous Graph/Chart) III-2
Chronic Obstructive Pulmonary Disease – Rise in Incidence Rates III-2
Table 45: Chronic Obstructive Pulmonary Disorder (COPD)
Incidence in US (2014): COPD Prevalence in Millions by Age
Group (includes analogous Graph/Chart) III-2
Sleep Apnea Devices: An Overview III-3
Competition III-3
Table 46: US Sleep Apnea Diagnostics Devices Market by
Leading Players (2014): Percentage Share Breakdown of Value
Sales for Compumedics, Embla, Grass Technologies, Nihon
Kohden, Philips Respironics and Others (includes
corresponding Graph/Chart) III-4

Table 47: US Sleep Apnea Therapeutics Devices Market by
Leading Players (2014): Percentage Share Breakdown of Value
Sales for Fisher and Paykel, Philips Respironics, ResMed
and Others (includes analogous Graph/Chart) III-4
Sleep Apnea Market Flourishes underneath a Influence of Myriad
Factors III-4
Increased Demand for Home Sleep Testing (HST) III-5
Table 48: US Sleep Apnea Diagnostic Devices Market (2012
2014): Percentage Breakdown of Revenue for HST Devices and
Other Devices (includes analogous Graph/Chart) III-5
Pricing Trends III-6
Price Erosion on a Rise III-6
Premium Products to Command Higher Prices III-6
Reimbursement Scenario III-6
Reimbursement Revisions to Boost OSA Market III-6
Home Sleep Tests Pose Significant Risk for Clinical
Polysomnographs III-7
Reimbursement Criteria for Sleep Apnea Diagnostic and
Therapeutic Devices – A Recent Past Perspective III-7
Table 49: Reimbursement Rates (In US$) of CPAP Devices:
2010 III-8
Average Replacement Schedules III-9
Distribution of Sleep Apnea Devices III-9
A Review of a Sleep Service Providers Market III-9
Greater Awareness Drives More Number of Sleep Labs III-9
Changeover of a Sleep Lab III-10
Inadequate Sleep Labs – A Bottleneck for Diagnosis of OSA III-10
Inadequate Sleep Labs Surge Development of Portable Sleep
Monitoring III-10
Product Launches III-11
Strategic Corporate Developments III-13
Key players III-17
B.Market Analytics III-23
Table 50: US Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Diagnostic Devices (Clinical/Fixed PSG, Ambulatory
PSG, and Others (Screening Devices)), and Therapeutic
Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces
(Masks and Humidifiers)) Markets Independently Analyzed with
Annual Sales in US$ Thousand for Years 2013 by 2020
(includes analogous Graph/Chart) III-23

Table 51: US Historic Review for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment – Diagnostic Devices
(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level
PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) III-24

Table 52: US 15-Year Perspective for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment – Percentage
Breakdown of Value Sales for Diagnostic Devices (Clinical/
Fixed PSG, Ambulatory PSG, and Others (Screening Devices)),
and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets for Years
2006, 2014, and 2020 (includes analogous Graph/Chart) III-25

2. CANADA III-26
A.Market Analysis III-26
Product Launches III-26
Corporate Development III-26
B.Market Analytics III-27
Table 53: Canadian Recent Past, Current Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Product Segment – Diagnostic Devices and Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Thousand for Years 2013 by 2020 (includes corresponding
Graph/Chart) III-27

Table 54: Canadian Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) III-28

Table 55: Canadian 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-29

3. JAPAN III-30
A.Market Analysis III-30
Japanese Continuous-Positive Airway Pressure (CPAP) Market III-30
Product Launches III-30
B.Market Analytics III-32
Table 56: Japanese Recent Past, Current Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Product Segment – Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) III-32

Table 57: Japanese Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and
Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets Independently Analyzed with Annual
Sales in US$ Thousand for Years 2006 by 2012 (includes
corresponding Graph/Chart) III-33

Table 58: Japanese 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
(Clinical/ Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level
PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
for Years 2006, 2014, and 2020 (includes corresponding
Graph/Chart) III-34

4. EUROPE III-35
A.Market Analysis III-35
Sleep Apnea Diagnostics – Overview III-35
Trends Issues III-36
Ambulatory PSGs Gaining over Clinical PSGs III-36
Insufficient Funds Improper Distribution Endanger Growth
of Sleep Apnea Diagnostics III-36
B.Market Analytics III-37
Market by Geographic Region III-37
Table 59: European Recent Past, Current Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Geographic Region – France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets Independently Analyzed
with Annual Sales in US$ Thousand for Years 2013 through
2020 (includes analogous Graph/Chart) III-37

Table 60: European Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region -
France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets Independently Analyzed with Annual Sales in
US$ Thousand for Years 2006 by 2012 (includes
corresponding Graph/Chart) III-38

Table 61: European 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region -
Percentage Breakdown of Value Sales for France, Germany,
Italy, UK, Spain, Russia, and Rest of Europe Markets for
Years 2006, 2014, and 2020 (includes corresponding
Graph/Chart) III-39
Market by Product Segment III-40
Table 62: European Recent Past, Current Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Product Segment – Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Thousand
for Years 2013 by 2020 (includes corresponding
Graph/Chart) III-40

Table 63: European Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/ Fixed PSG, Ambulatory PSG,
and Others (Screening Devices)), and Therapeutic Devices
(CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks
and Humidifiers)) Markets Independently Analyzed with
Annual Sales in US$ Thousand for Years 2006 by 2012
(includes analogous Graph/Chart) III-41

Table 64: European 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP,
Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets for Years 2006, 2014, and 2020
(includes analogous Graph/Chart) III-42

4a. FRANCE III-43
A.Market Analysis III-43
Outlook III-43
Strategic Corporate Developments III-43
B.Market Analytics III-44
Table 65: French Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) III-44

Table 66: French Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment – Diagnostic
Devices and Therapeutic Devices Markets Independently
Analyzed with Annual Sales in US$ Thousand for Years 2006
through 2012 (includes analogous Graph/Chart) III-45

Table 67: French 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-46

4b. GERMANY III-47
A.Market Analysis III-47
Weinmann Geräte für Medizin GmbH+CCo. KG – A Key Player III-47
B.Market Analytics III-48
Table 68: German Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) III-48

Table 69: German Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment – Diagnostic
Devices and Therapeutic Devices Markets Independently
Analyzed with Annual Sales in US$ Thousand for Years 2006
through 2012 (includes analogous Graph/Chart) III-49

Table 70: German 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-50

4c. ITALY III-51
A.Market Analysis III-51
Corporate Development III-51
B.Market Analytics III-52
Table 71: Italian Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) III-52

Table 72: Italian Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment – Diagnostic
Devices and Therapeutic Devices Markets Independently
Analyzed with Annual Sales in US$ Thousand for Years 2006
through 2012 (includes analogous Graph/Chart) III-53

Table 73: Italian 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-54

4d. THE UNITED KINGDOM III-55
A.Market Analysis III-55
Sleep Disorder: Factsheet III-55
Current and Future Analysis III-55
B.Market Analytics III-56
Table 74: UK Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) III-56

Table 75: UK Historic Review for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment – Diagnostic Devices
and Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Thousand for Years 2006 by 2012
(includes analogous Graph/Chart) III-57

Table 76: UK 15-Year Perspective for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment – Percentage
Breakdown of Value Sales for Diagnostic Devices and
Therapeutic Devices Markets for Years 2006, 2014, and 2020
(includes analogous Graph/Chart) III-58

4e. SPAIN III-59
Market Analysis III-59
Table 77: Spanish Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) III-59

Table 78: Spanish Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment – Diagnostic
Devices and Therapeutic Devices Markets Independently
Analyzed with Annual Sales in US$ Thousand for Years 2006
through 2012 (includes analogous Graph/Chart) III-60

Table 79: Spanish 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-61

4f. RUSSIA III-62
Market Analysis III-62
Table 80: Russian Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) III-62

Table 81: Russian Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment – Diagnostic
Devices and Therapeutic Devices Markets Independently
Analyzed with Annual Sales in US$ Thousand for Years 2006
through 2012 (includes analogous Graph/Chart) III-63

Table 82: Russian 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-64

4g. REST OF EUROPE III-65
A.Market Analysis III-65
Corporate Development III-65
B.Market Analytics III-66
Table 83: Rest of Europe Recent Past, Current Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Product Segment – Diagnostic Devices and Therapeutic
Devices Markets Independently Analyzed with Annual Sales in
US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) III-66

Table 84: Rest of Europe Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) III-67

Table 85: Rest of Europe 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-68

5. ASIA-PACIFIC III-69
Market Analysis III-69
Market by Geographic Region III-70
Table 86: Asia-Pacific Recent Past, Current Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Geographic Region – China, India, and Rest of
Asia-Pacific Markets Independently Analyzed with Annual
Sales in US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) III-70

Table 87: Asia-Pacific Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region -
China, India, and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales in US$ Thousand
for Years 2006 by 2012 (includes corresponding
Graph/Chart) III-71

Table 88: Asia-Pacific15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region -
Percentage Breakdown of Value Sales for China, India, and
Rest of Asia-Pacific Markets for Years 2006, 2014, and 2020
(includes analogous Graph/Chart) III-72
Market by Product Segment III-73
Table 89: Asia-Pacific Recent Past, Current Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Product Segment – Diagnostic Devices and Therapeutic
Devices Markets Independently Analyzed with Annual Sales in
US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) III-73

Table 90: Asia-Pacific Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand
for Years 2006 by 2012 (includes corresponding
Graph/Chart) III-74

Table 91: Asia-Pacific 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-75

5a. CHINA III-76
A.Market Analysis III-76
Corporate Developments III-76
B.Market Analytics III-77
Table 92: Chinese Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) III-77

Table 93: Chinese Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment – Diagnostic
Devices and Therapeutic Devices Markets Independently
Analyzed with Annual Sales in US$ Thousand for Years 2006
through 2012 (includes analogous Graph/Chart) III-78

Table 94: Chinese 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-79

5b. INDIA III-80
A.Market Analysis III-80
A High Potential Market III-80
B.Market Analytics III-81
Table 95: Indian Recent Past, Current Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2013 by 2020 (includes analogous Graph/Chart) III-81

Table 96: Indian Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment – Diagnostic
Devices and Therapeutic Devices Markets Independently
Analyzed with Annual Sales in US$ Thousand for Years 2006
through 2012 (includes analogous Graph/Chart) III-82

Table 97: Indian 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-83

5c. REST OF ASIA-PACIFIC III-84
A.Market Analysis III-84
Australia – A Significant Market for Sleep Apnea Therapeutic
Devices III-84
Product Launches III-84
Corporate Developments III-85
Key Players III-85
B.Market Analytics III-87
Table 98: Rest of Asia-Pacific Recent Past, Current Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Product Segment – Diagnostic Devices and Therapeutic
Devices Markets Independently Analyzed with Annual Sales in
US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) III-87

Table 99: Rest of Asia-Pacific Historic Review for Sleep
Apnea Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) III-88

Table 100: Rest of Asia-Pacific 15-Year Perspective for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Percentage Breakdown of Value Sales for Diagnostic
Devices and Therapeutic Devices Markets for Years 2006,
2014, and 2020 (includes analogous Graph/Chart) III-89

6. LATIN AMERICA III-90
Market Analysis III-90
Market by Geographic Region III-91
Table 101: Latin American Recent Past, Current Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Geographic Region – Brazil, and Rest of Latin American
Markets Independently Analyzed with Annual Sales in US$
Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) III-91

Table 102: Latin American Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region -
Brazil, and Rest of Latin American Markets Independently
Analyzed with Annual Sales in US$ Thousand for Years 2006
through 2012 (includes analogous Graph/Chart) III-92

Table 103: Latin American 15-Year Perspective for Sleep
Apnea Diagnostic and Therapeutic Devices by Geographic
Region – Percentage Breakdown of Value Sales for Brazil,
and Rest of Latin American Markets for Years 2006, 2014,
and 2020 (includes analogous Graph/Chart) III-93
Market by Product Segment III-94
Table 104: Latin American Recent Past, Current Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Product Segment – Diagnostic Devices and Therapeutic
Devices Markets Independently Analyzed with Annual Sales in
US$ Thousand for Years 2013 by 2020 (includes
corresponding Graph/Chart) III-94

Table 105: Latin American Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand
for Years 2006 by 2012 (includes corresponding
Graph/Chart) III-95

Table 106: Latin American 15-Year Perspective for Sleep
Apnea Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic
Devices and Therapeutic Devices Markets for Years 2006,
2014, and 2020 (includes analogous Graph/Chart) III-96

6a. BRAZIL III-97
Market Analysis III-97
Table 107: Brazilian Recent Past, Current Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Product Segment – Diagnostic Devices and Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Thousand for Years 2013 by 2020 (includes corresponding
Graph/Chart) III-97

Table 108: Brazilian Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) III-98

Table 109: Brazilian 15-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
and Therapeutic Devices Markets for Years 2006, 2014, and
2020 (includes analogous Graph/Chart) III-99

6b. REST OF LATIN AMERICA III-100
Market Analysis III-100
Table 110: Rest of Latin American Recent Past, Current
Future Analysis for Sleep Apnea Diagnostic and Therapeutic
Devices by Product Segment – Diagnostic Devices and
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Thousand for Years 2013 by 2020
(includes analogous Graph/Chart) III-100

Table 111: Rest of Latin American Historic Review for Sleep
Apnea Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices and Therapeutic Devices Markets
Independently Analyzed with Annual Sales in US$ Thousand for
Years 2006 by 2012 (includes analogous Graph/Chart) III-101

Table 112: Rest of Latin American 15-Year Perspective for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment – Percentage Breakdown of Value Sales for Diagnostic
Devices and Therapeutic Devices Markets for Years 2006,
2014, and 2020 (includes analogous Graph/Chart) III-102

7. MIDDLE EAST AND AFRICA III-103
A.Market Analysis III-103
Corporate Developments III-103
Itamar Med

Read a full report: http://www.reportlinker.com/p01048443-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning marketplace investigate resolution that finds, filters and organizes a latest attention information so we get all a marketplace investigate we need – instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To perspective a strange chronicle on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-sleep-apnea-diagnostic-and-therapeutic-devices-market-712043277.html

Humana, Key Medical Group and Kaweah Delta Health Care District Announce Value-Based, Integrated Delivery Arrangement …

VISALIA, Calif.–(BUSINESS WIRE)–

Improved health and some-more concurrent caring for Humana’s Medicare Advantage (MA) members in Tulare County is a idea behind a new fully-accountable, value-based partnership among Key Medical Group, Kaweah Delta Health Care District and Humana Inc. (HUM).

Humana, Key Medical Group and Kaweah Delta have assimilated efforts in a origination of an integrated smoothness complement that will outcome in some-more concurrent caring with an increasing importance on surety services for Humana Medicare Advantage members.

As partial of a multi-year partnership, Humana will be Key Medical Group’s disdainful Medicare Advantage HMO partner in Tulare County. Humana offers Medicare HMO plans, a remedy drug plan, and Medicare supplemental policies in a county.

Through Key Medical Group physicians, Humana’s Medicare Advantage members will have in-network entrance to Kaweah Delta facilities, including Kaweah Delta Medical Center and a understanding specialty facilities. Kaweah Delta Health Care District provides high-quality, customer-oriented and financially clever medical services that accommodate a opposite needs of those they serve.

“The new Key Medical Group, Kaweah Delta and Humana agreement will move improved studious caring coordination, some-more cost-effective peculiarity caring and a world-class studious knowledge to Humana members in Central California,” pronounced Lindsay Mann, Kaweah Delta’s Chief Executive Officer. “The arrangement will offer some-more personalized caring and a extended operation of race government collection like predictive analytics and ongoing care, illness government and wellness programs.”

“Key Medical Group is really vehement to be operative with Humana and Kaweah Delta on a origination of a Integrated Delivery System,” pronounced Dr. Onsy Said, Medical Director of Key Medical Group. “From physicians to box managers and health coaches, a new smoothness network will offer some-more concurrent caring and concentration on a health and contentment of a members.”

Key Medical Group is an Independent Physician Association (IPA) determined in 1993 with a goals and objectives to yield peculiarity caring to members and to have fair, efficient, and peculiarity medical government services for reserved members and participating providers. The IPA now binds contracts with 128 primary caring physicians and about 300 specialists in a Tulare and Kings counties.

“As we demeanour to tighten a opening for a members by creation entrance to caring easier and providing coordination of care, these forms of accountable partnerships are a vicious step for Humana in California,” pronounced Jim Brown, Humana’s California Market President for Senior Products. “Key Medical Group and Kaweah Delta are ideal partners in executive California. Our mutual joining to peculiarity helps us urge a health and contentment of Humana’s Medicare Advantage members.”

Humana aims to work closely with doctors and hospitals by a Accountable Care Continuum. The continuum is a stepped proceed to pay-for-value payment that allows a association to exercise opposite value-based partnerships with hospitals and doctors formed on their infrastructure and value-based payment capabilities.

The Humana/Key Medical Group/Kaweah Delta partnership emphasizes peculiarity outcomes with a concentration on caring coordination and leverages measures as tangible by a National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) like diabetes caring and treatment, breast cancer screenings, colorectal cancer screenings and high-risk medication.

Humana has a 26-year accountable caring attribute story with some-more than 1.2 million MA members that are cared for by 38,000 primary caring physicians, in some-more than 900 accountable caring relations opposite 43 states and Puerto Rico.

About Key Medical Group

Key Medical Group is an Independent Physician Association (IPA) determined in 1993 with a goals and objectives to yield peculiarity caring to members and to have fair, efficient, and peculiarity medical government services for reserved members and participating providers. The IPA now binds contracts with 128 primary caring physicians and about 300 specialists in a Tulare and Kings County area. The IPA manages medical caring for approximately 22,000 members in a dual counties.

About Kaweah Delta Health Care District

With some-more than 300 physicians and 3,600 employees – scarcely 1,000 of that are purebred nurses – Kaweah Delta Health Care District provides a people vital and operative in California’s bustling Central Valley with entrance to high-quality health caring only mins from home. Located in Tulare County, a heart of a state’s farming Central Valley, Kaweah Delta is a 581-bed, eight-campus medical district determined in 1961 and governed by a five-member house of directors. Offering general, specialty and sub-specialty caring in a full-range of medical fields (heart, lung, vascular, spine, childbirth, cancer, etc.)

About Humana

Humana Inc., headquartered in Louisville, Ky., is a heading health and contentment association focused on creation it easy for people to grasp their best health with clinical value by concurrent care. The company’s plan integrates caring delivery, a member experience, and clinical and consumer insights to inspire engagement, function change, active clinical overdo and wellness for a millions of people we offer opposite a country.

More information per Humana is accessible to investors around a Investor Relations page of a company’s web site during www.humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most new financier discussion presentations
  • Quarterly gain news releases
  • Replays of many new gain recover discussion calls
  • Calendar of events (including arriving gain discussion call dates and times, as good as designed communication with investigate analysts and institutional investors)
  • Corporate Governance information

MULTIMEDIA AVAILABLE:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50968823lang=en

Health caring workman being tested for probable Ebola during New York City hospital

ebolabellevue.jpg

Oct. 8, 2014: Health caring workers arrangement protecting gear, that sanatorium staff would wear to strengthen them from an Ebola pathogen infection, inside an siege room as partial of a media debate in a puncture dialect of Bellevue Hospital in Manhattan, New York. (REUTERS)

A health caring workman who recently returned from West Africa is being tested during a New York City sanatorium for probable Ebola, health officials pronounced Thursday.

The unclear alloy returned from one of a 3 West African countries cheerless with a illness within a past 21 days, and presented a heat and gastrointestinal symptoms, according to a matter from a commissioner of a New York City Department of Health and Mental Hygiene.

The studious was ecstatic to Bellevue Hospital in New York by a specifically lerned HAZ TAC section wearing Personal Protection Equipment (PPE).

Preliminary exam formula are approaching in a subsequent 12 hours, commissioner Mary Bassett pronounced in a statement. The Centers for Disease Control and Prevention (CDC) will also keep a blood representation from a studious officials pronounced in a statement. 

“As a serve precaution, commencement today, a Health Department’s group of illness detectives immediately began to actively snippet all of a patient’s contacts to brand anyone who might be during intensity risk,” Bassett said. 

“The Health Department staff has determined protocols to identify, forewarn and, if necessary, quarantine any contacts of Ebola cases,” she said. 

Bellevue Hospital is one of 8 hospitals designated by New York Gov. Andrew Cuomo to provide Ebola in a state. 

The Ebola conflict has putrescent scarcely 10,000 and killed during slightest 4,877. The 3 West African countries strike hardest by a pathogen are Liberia, Sierra Leone and Guinea. 

Mental health staffers will assist Jeffco sheriff's deputies with cases

The Jefferson County Center for Mental Health has a new participation within a Jeffco Sheriff’s Office interjection to a commander plan launched by a county and saved by a probity assistance grant.

The extend — for only over $125,000 — supports a county’s Crisis Intervention Team and pays salaries for dual full-time mental health dilettante box managers who will be stationed during a south patrol of a sheriff’s bureau and support deputies with cases that engage a think who could be traffic with mental health issues or someone who is constantly on a watch list during a sheriff’s office.

The box managers were recently hired and started work during a commencement of a month.

„We’re anticipating to see augmenting entrance to mental health services and to diminution a time sheriff’s deputies have to spend on mental health calls,” pronounced Lori Swanson-Lamm, executive of adult complete services during Jefferson County Center for Mental Health.

The sheriff’s bureau has seen an augmenting series of cases that understanding with mental health issues. In 2013, deputies perceived roughly 600 calls associated to mental issues, adult from 200 in 2003, according to Swanson-Lamm, who pronounced a bureau is on gait to transcend a 2013 series this year.

In a past few years, sheriff’s deputies who are partial of a Crisis Intervention Team have been holding an augmenting purpose in shortcoming per mental health cases, even including holding a chairman they had hit with to Jefferson County Mental Health for an appointment with a therapist. That was finished on a proffer basement with a vigilant of removing people improved entrance to services.

„It’s always been my opinion that we concentration on removing mentally ill people to facilities,” Capt. Al Simmons said.

The sheriff’s bureau had been looking for improved ways to bond with people who might be pang from a mental health emanate and sat down with a county attorney’s bureau and Mental Health Services to come adult with a offer for a dual box managers.

„There are lots of people who are frequently on a radar for a sheriff’s office,” partner county profession Joan Heller said. „It’s a advantage to a community.”

The box managers have spent a past month removing acclimated and going on ride-alongs with Crisis Intervention Team members.

The Jefferson County Center for Mental Health and a Jeffco Sheriff’s Office have been collaborating given 2000, and Swanson-Lamm pronounced she’s happy to see this subsequent step in a process.

„It’s implausible to see a buy-in from Sheriff (Ted) Mink all a approach down,” she said.

Joe Vaccarelli: 303-954-2396, jvaccarelli@denverpost.com or twitter.com/joe_vacc